Mobidiag launches Novodiag® a new diagnostic solution for infectious diseases

The end of 2017 has been marked by a key event for Mobidiag, the launch of the Novodiag® solution at the Finnish Embassy in Paris (France) with the support of M. Ambroise Fayolle, VP of the EIB (European Investment Bank) and Dr. Etienne Ruppé, MCU-PH/Associate Professor, bacteriology department at Bichat hospital (Paris, France).

The new Novodiag® solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results within a few hours. In a time where antibiotic resistance is a major threat for global health, the optimized process offered by Novodiag allows, among other things, to detect antibiotic resistance and limit the systematic use of antibiotics. This instrument allows detection of infectious diseases in a few hours and supports infection management accordingly.

Continue Reading

RICAI 2017, Paris, France

C. Burucoa, B. Pichard, T. Barrioz, F. Prevost, M. Wangermez, G. Fotsing, P-A. Haineaux, L. Serres, E. Vuillemin, P. Vasseur, F. Charier, E. Pithon, C. Plouzeau, J. Cremniter, A. Michaud, C. Silvain; Performances de la PCR Amplidiag Helicobacter pylori dans les selles.
Learn more about Amplidiag® H. pylori+ClariR.

See Poster

C. Hays, C. Burucoa, D. Lamarque, N. Kalach, G. Collobert, A. Billoet, C. Plainvert, J. Raymond; Diagnostic de l’infection à Helicobacter pylori sur biopsie gastriques: évaluation du kit Amplidiag® H. pylori+ClariR.
Learn more about Amplidiag® H. pylori+ClariR.

Continue Reading

Mobidiag Signs Agreement with Interlux for the Distribution of Amplidiag® Diagnostic Tests and Instrument in Estonia

Mobidiag Ltd today announced a distribution agreement with Interlux OÜ, supplier of technologies for medicine, science and biotechnology industry. Under this agreement, Interlux becomes the exclusive distributor of the Amplidiag® product line in Estonia, in vitro diagnostic tests and compatible instrument for the detection of gastrointestinal infections.

ESPOO, Finland, November 23rd, 2017 Mobidiag Ltd. today announced a distribution agreement with Interlux OÜ, supplier of technologies for medicine, science and biotechnology industry. Under this agreement, Interlux becomes the exclusive distributor of the Amplidiag® product line in Estonia, in vitro diagnostic tests and compatible instrument for the detection of gastrointestinal infections.

Continue Reading

Mobidiag symposium at the RICAI 2017. Save your seat now!

Do not miss our RICAI symposium on December 18th (12 :45pm-1 :45pm), Palais des Congrès Porte Maillot, 75017 Paris, France, and discover what molecular biology can bring to your everyday work in your lab.

Mobidiag will attend the RICAI 2017 (Réunion Interdisciplinaire de Chimiothérapie Anti Infectieuse), in Paris, France, December 18-19, 2017.

Do not miss our RICAI symposium on December 18th (12 :45pm-1 :45pm), Palais des Congrès Porte Maillot, 75017 Paris, France.

Ne manquez pas notre symposium du 18 décembre (12h45-13h45) pour échanger sur vos méthodes actuelles de microbiologie et découvrir ce que la biologie moléculaire peut vous apporter.

Continue Reading

Mobidiag featured in TECAN journal

The article “Perfect synergy for molecular diagnostics” covers the partnering between Mobidiag and TECAN for the development of the Amplidiag® Easy system, the automated platform for nucleic acid extraction and PCR plate set-up. Amplidiag Easy enables high volume screening and antibiotic resistance testing for gastrointestinal pathogens directly from stool samples.

Discover compatible Amplidiag multiplex real-time qPCR tests compatible with Amplidiag Easy.

Read full article here.

Continue Reading

Mobidiag Announces Release of Amplidiag® Viral GE, a Multiplex PCR Test to Detect Gastrointestinal Viruses Directly from Stool Samples

Mobidiag Ltd today announced the CE-IVD marking of Amplidiag® Viral GE, a molecular test allowing simultaneous detection of the main enteric viruses causing diarrhea. The available panel includes norovirus GI, norovirus GII, rotavirus, sapovirus, astrovirus, adenovirus 40 and 41.

Download pdf version.

ESPOO, Finland, June 26h, 2017 – Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the CE-IVD marking of Amplidiag® Viral GE, a molecular test allowing simultaneous detection of the main enteric viruses causing diarrhea. The available panel includes norovirus GI, norovirus GII, rotavirus, sapovirus, astrovirus, adenovirus 40 and 41.

Continue Reading